The Global Bioactive Materials Market was valued at USD 2.20 bn in 2020 and is expected to reach USD 7.22 bn by 2027, with a growing CAGR of 15.2% during the forecast period.
Bioactive materials are essential bone substitutes in clinical practise. A bio active material is a substance that has been engineered to interact with biological systems for a medical purpose, either a therapeutic or a diagnostic one. However, bioactive materials cannot replace all autografts (patient’s own tissue). Bioactive materials with improved bone-bonding ability and diverse mechanical characteristics are required to conduct surgeries. In the live organism, most bioactive materials create an appetite layer (a thin film of carbonate-containing HA with small crystallites and defective structures similar to apatite in natural bone.) on their surfaces and then attach to bone.
Increasing demand for implantable in healthcare sector is anticipated to drive the bioactive materials market growth in the near future. Bioactive materials are widely used in plastic surgery and body reconstruction, including tissue augmentation, craniofacial reconstruction with bone and skin substitutes and soft-tissue fillers, wound treatment, and scar-reduction technologies. For instance, according to WHO the global organ transplant in 2019, reached 153,863 in which 37.4% were living kidney transplants. Additionally, rise in governmental initiatives for medical research is expected to bolster the bioactive materials demand throughout the forecast period. For instance, the ‘Ministry of Health and Family Welfare of the Government of India’ is operating the National Oral Health Program under the flagship of the National Health Mission, in which the, SDF (Silver Diamine Fluoride) gained popularity in India. A number of Indian researchers trying SDF in dental procedures for various objectives, such as using SDF as pulp capping material. Nevertheless, complex procedure for manufacturing of bioactive materials may hinder the market growth during the forecast period.
The unique insights provided by this report also include the following:
Based on form, powder segment is expected to bolster the market demand during the forecast period due to its application in complex organ structures
Based on form, the market is segmented into granules, moulded and powder. The powders segment held the largest market share in 2020 and is projected to remain dominant during the forecast period. Bioactive glass powder is used in regeneration of bone cells. Bioactive glass powder is compatible with human body and comprises of osteogenic capacity that helps in enamel construction, and tissue engineering. Thus, the use bioactive glass powders in regeneration of bone cells are anticipated to foster the market growth during the forecast period.
Based on application, the dental segment in the bioactive materials market is expected to hold the largest market share during the forecast period owing to its delicate, handling
Based on application, the market has been segmented into bioengineering, dental, surgical, and others. Dental segment held the largest market share during the forecast period due to its delicate handling. In this segment bioactive glass is used for dental adhesives, enamel remineralization, dentin hypersensitivity, air abrasion, restorative materials, pulp capping and root canal therapy, bone regeneration, in periodontics. For instance, according to WHO, oral disease nearly affects 3.5 billion of population annually, and more than 530 million children suffer from dental caries of primary teeth. The use of bioactive materials in dental surgeries is expected to drive the bioactive materials market growth during the forecast period.
Based on region, North America held the largest market share during the forecast period
Based on region, the global bioactive materials market is split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest market share during the forecast period. According to CDC, in 2019, over 659,041 of the US citizens had to witness death due to major heart disease. Therefore, the use of bioactive materials in heart replacement surgeries is anticipated to drive the market growth during the forecast period. Additionally, the use of bioactive materials to replace limbs or other body parts is expected to foster the market demand. For instance, according to CDC in 2019, the number of unintentional accidental injuries were 173, 040.
Moreover, Asia-Pacific is expected to significantly contribute to the market growth during the forecast period, owing to its research & geriatric population. For instance, according to Japan Times, the estimated number of people aged 65 or older in Japan rose to 36.4 million in 2021, an increase of 220,000 from a year before. The total number of expected cardiovascular operations peaked in 2020 with an estimated 61,506 operations.
The report also provides an in-depth analysis of bioactive materials market dynamics such as drivers, restraints, opportunities, and challenges
The coronavirus disease 2019 (COVID-19) pandemic has shown fundamental flaws in our ability to prevent infectious viral illness transmission and provide treatment to victims, concluding in a public health disaster. COVID-19 demonstrates that the bioactive materials community focused major research efforts on bacteria and fungi while focusing comparatively lesson viruses. Bioactive materials researchers by first offering a brief overview of existing clinical standards, followed by potential for bioactive materials intervention. The market is expected to find many opportunities in testing of Sars Cov-2 multidisciplinary approaches involving bioactive materials. This testing procedures are expected to play a significant role in disease detection and management in many cases. Bioactive materials were used in nucleic acid testing, isothermal RT-PCR tests, protein testing, viral antigen testing. Moreover, in addition to diagnostics development, bioactive material technologies can be used to develop novel treatment strategies for effective management of COVID-19 infection. This includes antiviral therapy, for instance, traditional antiviral therapies can be classified into non-specific antiviral agents (e.g., ribavirin, remdesivir, chloroquine) and targeted inhibitors of a specific viral element (e.g., HIV protease inhibitors, RNAi). In addition, immunomodulatory agents (e.g., interferons and corticosteroids) have been used to decrease the inflammatory state associated with viral infection. These therapies are advantageous but also have major limitations. Nonspecific antivirals are generally more prophylactic, not effective against all viruses, and can have significant side effect profiles.
The report also provides an in-depth analysis of key trends in the bioactive materials market
The report also provides an in-depth analysis of recent news developments and investments
The key players operating in the bioactive materials market are:
Priyanka has been writing chemicals & material market research reports for the last 12 years. A post-graduate, her specialization is in the chemicals sector. Preparing end-to-end reports covering minute details for market insights, competitive intelligence and trend analysis in the CMFE sector.